Jiangsu Sihuan Bioengineering Co., Ltd. operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Sihuan Bioengineering Co., Ltd. with three other
companies in this sector in China:
Shanghai Jiaoda Onlly Co., Ltd.
sales of 282.07 million Chinese Renmimbi [US$41.20 million]
of which 91%
Zhejiang Wolwo Bio Pharmaceutical Co Ltd
(385.58 million Chinese Renmimbi [US$56.31 million]
of which 99%
was Pharmaceutical Manufacturing), and
Shanghai Hile Bio-Technology Co Ltd
(303.65 million Chinese Renmimbi [US$44.35 million]
of which 100%
was Animal Vaccine).
During the year ended December of 2017, sales at
Jiangsu Sihuan Bioengineering Co., Ltd. were 345.94 million Chinese Renmimbi (US$50.53 million).
increase of 5.8%
versus 2016, when the company's sales were 326.95 million Chinese Renmimbi.